All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Mounjaro and Fertility

Mounjaro should be discontinued at least one month before trying to conceive. Learn about its fertility effects, weight loss benefits for reproduction,...

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Mounjaro should be discontinued at least one month before trying to conceive. Learn about its fertility effects, weight loss benefits for reproduction, contraception guidance, and PCOS impact.

Mounjaro (tirzepatide) should be discontinued at least one month before you try to become pregnant. It isn't approved for use during pregnancy. But the dramatic weight loss many patients experience on Mounjaro can positively impact fertility by restoring hormonal balance and ovulatory function in those affected by obesity. Working with your provider on timing is critical.

Mounjaro was originally approved for type 2 diabetes, but its weight loss effects have made it one of the most talked-about medications in reproductive health circles. Many patients prescribed Mounjaro are women in their 20s, 30s, and 40s who are actively thinking about family planning.

When to Stop Mounjaro Before Conception

Tirzepatide, the active ingredient in Mounjaro, has a half-life of about five days. After your final injection, it takes roughly four to five weeks for the drug to be effectively eliminated. The prescribing information recommends stopping at least one month before planned pregnancy.

This recommendation is based on animal studies where high doses of tirzepatide caused adverse developmental effects in offspring. Human pregnancy data isn't available in sufficient quantity to override this precaution. Planning your washout period in advance with your fertility team ensures a smooth transition from treatment to conception.

How Mounjaro Weight Loss Supports Fertility

Obesity impairs fertility through multiple pathways: excess estrogen from fat tissue, insulin resistance disrupting ovulation, chronic inflammation affecting egg and sperm quality, and higher rates of pregnancy complications. Mounjaro addresses several of these through substantial weight reduction and metabolic improvement. For a complete cost breakdown, see our compare tirzepatide pharmacies.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Mounjaro and Fertility

Patients on Mounjaro in clinical trials lost an average of 15% to 22.5% of their body weight at the highest doses. For someone weighing 250 pounds, that translates to losing 37 to 56 pounds. This magnitude of change can shift a patient from anovulatory to regularly ovulating, from failed IVF cycles to successful ones, and from high-risk pregnancy territory to much safer ground.

Mounjaro and PCOS

Polycystic ovary syndrome is closely linked to insulin resistance and weight. Mounjaro's dual GIP/GLP-1 mechanism addresses both of these factors directly. By improving insulin sensitivity and reducing body weight, Mounjaro may help PCOS patients resume regular ovulatory cycles.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

This is a double-edged sword for patients not trying to conceive. If you have PCOS and start ovulating again while on Mounjaro, your risk of unplanned pregnancy increases. Use consistent contraception if pregnancy isn't desired. tirzepatide and PCOS

Contraception on Mounjaro

Mounjaro's prescribing information warns that delayed gastric emptying may reduce the effectiveness of oral hormonal contraceptives. The recommendation is to use an additional non-oral backup method for four weeks after starting Mounjaro and for four weeks after each dose increase. IUDs, contraceptive implants, patches, and injectable contraceptives aren't affected by gastric motility changes.

Frequently Asked Questions

How long before conception should I stop Mounjaro?

Stop Mounjaro at least one month before trying to conceive. Given tirzepatide's five-day half-life, the drug should be substantially cleared from your body within that timeframe. Your provider may recommend a slightly longer window depending on your circumstances.

Can Mounjaro cause permanent infertility?

There's no evidence that Mounjaro causes permanent infertility in humans. The precautionary recommendation to stop before pregnancy is based on animal study findings at doses exceeding human therapeutic levels. For many patients, Mounjaro's weight loss benefits may actually enhance fertility.

What should I do if I get pregnant while on Mounjaro?

Discontinue Mounjaro immediately and contact your healthcare provider. The effects of early-pregnancy exposure to tirzepatide in humans aren't well studied. Your provider will arrange appropriate monitoring and guide next steps.

Does Mounjaro affect oral birth control?

Mounjaro may reduce oral contraceptive absorption because it delays gastric emptying. The prescribing label recommends a backup non-oral contraceptive method for four weeks after starting Mounjaro and after each dose increase. Non-oral options like IUDs and implants remain fully effective. GLP-1 drug interactions

Potentially, yes. Weight loss and improved insulin sensitivity from Mounjaro may restore ovulation in women with PCOS. Some reproductive specialists use a weight loss phase with Mounjaro before fertility treatment, followed by a proper washout period before conception attempts. Mounjaro for weight loss

This content is for informational purposes only and doesn't constitute medical advice. Always consult a qualified healthcare provider regarding fertility and medication decisions.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Mounjaro and Fertility custom 2026 header image for GLP-1 Weight Loss
Custom header image for Mounjaro and Fertility, GLP-1 Weight Loss, and better treatment decision-making.

Research Snapshot

Medication guide
Page type
Medication guide
Page metadata
Page updated
2026-04-01
Page metadata
Mounjaro official website
Official source
Retatrutide official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-04-01.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Mounjaro and Fertility research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.